Technical Analysis for SVRA - Savara, Inc.

Grade Last Price % Change Price Change
grade F 8.93 -2.19% -0.20
SVRA closed down 2.19 percent on Monday, May 21, 2018, on 66 percent of normal volume.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical SVRA trend table...

Date Alert Name Type % Chg
May 21 Down 3 Days in a Row Weakness 0.00%
May 21 Down 4 Days in a Row Weakness 0.00%
May 21 Oversold Stochastic Weakness 0.00%
May 18 MACD Bearish Signal Line Cross Bearish -2.19%
May 18 BB Squeeze Ended Range Expansion -2.19%
May 18 Down 3 Days in a Row Weakness -2.19%
May 18 Oversold Stochastic Weakness -2.19%
May 17 50 DMA Resistance Bearish -4.49%
May 17 MACD Bearish Centerline Cross Bearish -4.49%
May 17 Bollinger Band Squeeze Range Contraction -4.49%

Older signals for SVRA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Savara Inc., formerly Mast Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of novel therapies for the treatment of patients with rare respiratory diseases. Its pipeline includes AeroVanc, Molgradex and AIR001. AeroVanc is an inhaled formulation of vancomycin, which the Company is developing for the treatment of persistent methicillin-resistant Staphylococcus aureus, lung infection in cystic fibrosis patients. Molgradex is an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor. It is developing Molgradex for the treatment of autoimmune pulmonary alveolar proteinosis, a rare lung disease. AIR001 is a sodium nitrite solution for inhalation via nebulization. AIR001 is in Phase II clinical development for the treatment of heart failure with preserved ejection fraction, also known as diastolic heart failure or heart failure with preserved systolic function.
Is SVRA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 17.19
52 Week Low 4.6
Average Volume 128,265
200-Day Moving Average 10.2361
50-Day Moving Average 9.4596
20-Day Moving Average 9.363
10-Day Moving Average 9.451
Average True Range 0.4336
ADX 18.72
+DI 12.01
-DI 24.18
Chandelier Exit (Long, 3 ATRs ) 8.6992
Chandelier Exit (Short, 3 ATRs ) 9.8708
Upper Bollinger Band 10.0182
Lower Bollinger Band 8.7078
Percent B (%b) 0.17
BandWidth 13.995514
MACD Line -0.0708
MACD Signal Line -0.0354
MACD Histogram -0.0353
Fundamentals Value
Market Cap 216.14 Million
Num Shares 24.2 Million
EPS -3.50
Price-to-Earnings (P/E) Ratio -2.55
Price-to-Sales 526.42
Price-to-Book 2.64
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.58
Resistance 3 (R3) 9.59 9.38 9.47
Resistance 2 (R2) 9.38 9.22 9.38 9.43
Resistance 1 (R1) 9.16 9.12 9.06 9.15 9.40
Pivot Point 8.95 8.95 8.90 8.95 8.95
Support 1 (S1) 8.73 8.79 8.63 8.72 8.46
Support 2 (S2) 8.52 8.69 8.52 8.43
Support 3 (S3) 8.30 8.52 8.39
Support 4 (S4) 8.29